These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35333990)

  • 1. Gut flora alterations due to lipopolysaccharide derived from Porphyromonas gingivalis.
    Sugiyama N; Uehara O; Morikawa T; Paudel D; Ebata K; Hiraki D; Harada F; Yoshida K; Kato S; Nagasawa T; Miura H; Abiko Y; Furuichi Y
    Odontology; 2022 Oct; 110(4):673-681. PubMed ID: 35333990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome.
    Kato T; Yamazaki K; Nakajima M; Date Y; Kikuchi J; Hase K; Ohno H; Yamazaki K
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Porphyromonas gingivalis on the gut microbiome of mice in relation to aging.
    Giri S; Uehara O; Takada A; Paudel D; Morikawa T; Arakawa T; Nagasawa T; Abiko Y; Furuichi Y
    J Periodontal Res; 2022 Dec; 57(6):1256-1266. PubMed ID: 36251393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver.
    Nakajima M; Arimatsu K; Kato T; Matsuda Y; Minagawa T; Takahashi N; Ohno H; Yamazaki K
    PLoS One; 2015; 10(7):e0134234. PubMed ID: 26218067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Porphyromonas gingivalis in gut microbiota of streptozotocin-induced diabetic mice.
    Ohtsu A; Takeuchi Y; Katagiri S; Suda W; Maekawa S; Shiba T; Komazaki R; Udagawa S; Sasaki N; Hattori M; Izumi Y
    Oral Dis; 2019 Apr; 25(3):868-880. PubMed ID: 30667148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Porphyromonas gingivalis infection on gut dysbiosis and resultant arthritis exacerbation in mouse model.
    Hamamoto Y; Ouhara K; Munenaga S; Shoji M; Ozawa T; Hisatsune J; Kado I; Kajiya M; Matsuda S; Kawai T; Mizuno N; Fujita T; Hirata S; Tanimoto K; Nakayama K; Kishi H; Sugiyama E; Kurihara H
    Arthritis Res Ther; 2020 Oct; 22(1):249. PubMed ID: 33076980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Administration of Lipopolysaccharide from
    Morikawa T; Uehara O; Paudel D; Yoshida K; Harada F; Hiraki D; Sato J; Matsuoka H; Kuramitsu Y; Michikawa M; Abiko Y
    In Vivo; 2023; 37(1):163-172. PubMed ID: 36593043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Pathobiont-Induced Changes in Gut Microbiota Aggravate the Pathology of Nonalcoholic Fatty Liver Disease in Mice.
    Yamazaki K; Kato T; Tsuboi Y; Miyauchi E; Suda W; Sato K; Nakajima M; Yokoji-Takeuchi M; Yamada-Hara M; Tsuzuno T; Matsugishi A; Takahashi N; Tabeta K; Miura N; Okuda S; Kikuchi J; Ohno H; Yamazaki K
    Front Immunol; 2021; 12():766170. PubMed ID: 34707622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli: Differential and interactive effects on novelty-induced hyperlocomotion, blood cytokine levels and TLR4-related processes.
    Aono Y; Saito K; Kawashima H; Watanabe A; Kono T; Hashizume-Takizawa T; Okada H; Kosuge Y; Senpuku H; Waddington JL; Saigusa T
    PLoS One; 2024; 19(6):e0292830. PubMed ID: 38857232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of three oral pathogens on the TMA-TMAO metabolic pathway.
    Wang X; Chen L; Teng Y; Xie W; Huang L; Wu J; Wang H; Xie S
    Front Cell Infect Microbiol; 2024; 14():1413787. PubMed ID: 38836053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyromonas gingivalis lipopolysaccharide induces cognitive dysfunction, mediated by neuronal inflammation via activation of the TLR4 signaling pathway in C57BL/6 mice.
    Zhang J; Yu C; Zhang X; Chen H; Dong J; Lu W; Song Z; Zhou W
    J Neuroinflammation; 2018 Feb; 15(1):37. PubMed ID: 29426327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice.
    Feng YK; Wu QL; Peng YW; Liang FY; You HJ; Feng YW; Li G; Li XJ; Liu SH; Li YC; Zhang Y; Pei Z
    J Neuroinflammation; 2020 Nov; 17(1):347. PubMed ID: 33213462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porphyromonas gingivalis impairs glucose uptake in skeletal muscle associated with altering gut microbiota.
    Watanabe K; Katagiri S; Takahashi H; Sasaki N; Maekawa S; Komazaki R; Hatasa M; Kitajima Y; Maruyama Y; Shiba T; Komatsu K; Ohsugi Y; Tanaka K; Matsuzawa A; Hirota T; Tohara H; Eguchi Y; Anzai K; Hattori A; Iwata T
    FASEB J; 2021 Feb; 35(2):e21171. PubMed ID: 33197074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthy and Inflamed Gingival Fibroblasts Differ in Their Inflammatory Response to Porphyromonas gingivalis Lipopolysaccharide.
    Kang W; Hu Z; Ge S
    Inflammation; 2016 Oct; 39(5):1842-52. PubMed ID: 27525424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An orally administered oral pathobiont and commensal have comparable and innocuous systemic effects in germ-free mice.
    Sato K; Yokoji M; Yamada M; Nakajima T; Yamazaki K
    J Periodontal Res; 2018 Dec; 53(6):950-960. PubMed ID: 30047130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles derived from Porphyromonas gingivalis induce trigeminal nerve-mediated cognitive impairment.
    Ma X; Shin YJ; Yoo JW; Park HS; Kim DH
    J Adv Res; 2023 Dec; 54():293-303. PubMed ID: 36796586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9-producing CD4
    Sohn J; Li L; Zhang L; Settem RP; Honma K; Sharma A; Falkner KL; Novak JM; Sun Y; Kirkwood KL
    Mol Oral Microbiol; 2022 Apr; 37(2):42-52. PubMed ID: 34958712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli.
    Martin M; Katz J; Vogel SN; Michalek SM
    J Immunol; 2001 Nov; 167(9):5278-85. PubMed ID: 11673543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Porphyromonas gingivalis and Escherichia coli lipopolysaccharides on mononuclear phagocytes.
    Roberts FA; Richardson GJ; Michalek SM
    Infect Immun; 1997 Aug; 65(8):3248-54. PubMed ID: 9234782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calprotectin expression in human monocytes: induction by porphyromonas gingivalis lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1beta.
    Kido J; Hayashi N; Kataoka M; Nagata T
    J Periodontol; 2005 Mar; 76(3):437-42. PubMed ID: 15857079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.